L’impact de la Mélatonine dans le traitement de maladies cardio-vasculaires: progres de l’année dernière

Nouvelles études indiquant les propriétés thérapeutiques de la Mélatonine dans le traitement de maladies cardio-vasculaires. Les recherches ont montré d' effects significatifs de la mélatonine dans cas d'ischémie périphérique,  l'hypertension, maladies de valve cardiaque, maladies vasculaires et le métabolisme des lipides. La mélatonin peut être une nouvelle option pour le traitement de maladies cardio-vasculaires.

Effects of melatonin ( mélatonine )on cardiovascular diseases: progress in the past year.
Curr Opin Lipidol. 2016 Apr 12;
Authors: Sun H, Gusdon AM, Qu S

Abstract
PURPOSE OF REVIEW: Melatonin is a neuroendocrine hormone synthesized primarily by the pineal gland. Numerous studies have suggested that melatonin ( mélatonine )plays an important role in various cardiovascular diseases. In this article, recent progress regarding melatonin's effects on cardiovascular diseases is reviewed.
RECENT FINDINGS: In the past year, studies have focused on the mechanism of protection of melatonin ( mélatonine )on cardiovascular diseases, including myocardial ischemia-reperfusion injury, myocardial hypoxia-reoxygenation injury, pulmonary hypertension, hypertension, atherosclerosis, valvular heart diseases, and other cardiovascular diseases.
SUMMARY: Studies have demonstrated that melatonin ( mélatonine )has significant effects on ischemia-reperfusion injury, myocardial chronic intermittent hypoxia injury, pulmonary hypertension, hypertension, valvular heart diseases, vascular diseases, and lipid metabolism. As an inexpensive and well tolerated drug, melatonin ( mélatonine )may be a new therapeutic option for cardiovascular disease.

PMID: 27075419 [PubMed - as supplied by publisher]
http://www.ncbi.nlm.nih.gov/pubmed/27075419?dopt=Abstract